期刊文献+

急性脑梗死患者同型半胱氨酸、脂蛋白(a)和超敏C反应蛋白检测的临床意义 被引量:9

下载PDF
导出
摘要 脑梗死又称缺血性脑卒中,是一种发病率、致残率、病死率都很高的疾病,是老年人致残和认知障碍的主要原因。脑梗死是多种危险因素单纯或共同作用的结果,文献报道,同型半胱氨酸(homecysteine, Hcy)和脂蛋白(葬)[Lipoprotein(a),LP(a)]是导致动脉粥样硬化的危险因素,在脑血管病的发生发展中具有重要意义[1-2]。而超敏C反应蛋白(hs-CRP)是一重要的血管炎性因子,大量实验表明其参与了脑梗死的发病过程[3]。为此,本研究联合检测了117例急性脑梗死(acute cerebral infarc-tion,ACI)患者血Hcy、LP(a)和hs-CRP水平,分析三者与急性脑梗死的相关性,探讨ACI的诊断和治疗预后判断指标。
作者 徐伟锋
出处 《浙江中西医结合杂志》 2014年第9期790-791,共2页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献14

  • 1徐艳红,刘进香.进展性脑梗死血浆Hcy及hs-CRP水平测定及其临床意义[J].神经病学与神经康复学杂志,2009,6(3):184-186. 被引量:9
  • 2丁琳,熊丽华,吕勇.血清hs-CRP水平与急性脑梗死预后的关系[J].浙江检验医学,2007,0(2):47-47. 被引量:2
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33009
  • 4Ueland PM.Homocysteine species as components of plasmaredox thiol status[J].Canadian Metallurgical Quarterly, 1995,41(3):340-342.
  • 5Refsum H,Smith AD,Ueland PM,et al.Facts and recom-mendations about total homocysteine determinationsiall ex-pert opinion [j].Clin Chem, 2004,50( 1) : 3-32.
  • 6Stuhlinger MC,Oka RK,Graf EE,et al. Endothelial dys-function indued by hyperhomocyst (e ) inemia:role of asym-metric dimethylarginine [j].Circulation, 2003,108(8):933-938.
  • 7Thambyrajah J,Townend JN.Homocysteine and atherothrom-bosis -mechanisms for injury [ J ] .European Heart Journal,2000,21(12):967-974.
  • 8Hankey GJ,Eikelboom JW.Homocysteine levels in patientswith stroke : clinical relevance and therapeutic implications[J].CNS drugs,2001,15(6) :437-443.
  • 9Guthikonda S, Haynes WG.Homocysteine as a novel riskfactor for atherosclerosis [j ].Current opinion in cardiology,1999,14(4):283-291.
  • 10Koschinsky ML.Novel insights into Lp(a) physiology andpathogenicity: more questions than answers [j].CardiovascHematol Disord Drug Targets,2006,6(4):267-278.

二级参考文献14

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15713
  • 2[1]Maseri A. Inflammation, atherosclerosis, and ischemic events-exploring the hidden side of the moon. New Engl J Med,1997,336:1014-1016.
  • 3[2]Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33:309-315.
  • 4[3]Stern MP. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes, 1995,44:369-374.
  • 5[4]Barzilay JI, Abraham Linn, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes, 2001,50:2384-2388.
  • 6[1]Ofosu-Appiah W,Huang LY,Kuhnle M,et al.Autoantibodies against arterial antigens:characterization by ELISA and immunoblot analysis in the spontaneously hypertensive rats.Clin Exp Hypertens,1996,18:21-27.
  • 7[2]Finazzi G,Brancaccio V,Moia M,et al.Natural history and risk factor for thrombosis in 360 patients with antiphospholipide antibodies,a four-years prospective study from the Italian registry.Am J Med,1996,100:500-506.
  • 8[3]Ross R.Atherosis,An inflammatory disease.N Engl J Med,1999,340:115-126.
  • 9[4]Deveraj S,Xu DY,Jialai I.C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherosclerosisombosis.Circulation,2003,107:398-404
  • 10[5]Zwaka TP,Hombach V,Torzewski J.C-reactive protein mediated low density lipoprotein uptake by macrophages implications for atherosclerosis.Circulation,2001,103:1194-1197.

共引文献33473

同被引文献71

引证文献9

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部